Literature DB >> 2885485

Adverse reaction to 5-HT3 antagonist ICS 205930.

M Coupe.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2885485     DOI： 10.1016/s0140-6736(87)92246-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

2.  5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.

Authors:  C R Pinkerton; D Williams; C Wootton; S T Meller; T J McElwain
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.